Patent · US Active

Antibody specifically binding to insulin-like growth factor-1

US10301383B2 · kind B2 · utility

0Cited by

2References

1Claims

0Family size

Assignee

Roche Diagnostics Operations, Inc. · US

Inventors

Herbert Andres · Penzberg, DE
Hartmut Duefel · Schlehdorf, DE
Michael Gerg · Munich, DE
Frank Kowalewsky · Munich, DE
Christian Scholz · Penzberg, DE
Michael Schraemi · Penzberg, DE

Key dates

Filing date	Jan 22, 2016
Grant date	May 28, 2019
Priority date	—
Expiry date	Jul 24, 2036

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/99
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Isolated antibodies that specifically bind to an epitope comprised in the stretch of amino acids ranging from amino acid 76 to amino acid 84 of human insulin-like growth factor-1 precursor (SEQ ID NO:1). Use of the novel antibodies for the sensitive and specific detection of insulin-like growth factor-1, in some embodiments while in the presence of high excess concentration of insulin-like growth factor-2, for example in a bodily fluid sample.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.